GB201906291D0 - Treatment and prevention of metabolic diseases - Google Patents
Treatment and prevention of metabolic diseasesInfo
- Publication number
- GB201906291D0 GB201906291D0 GBGB1906291.8A GB201906291A GB201906291D0 GB 201906291 D0 GB201906291 D0 GB 201906291D0 GB 201906291 A GB201906291 A GB 201906291A GB 201906291 D0 GB201906291 D0 GB 201906291D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prevention
- treatment
- metabolic diseases
- metabolic
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1906291.8A GB201906291D0 (en) | 2019-05-03 | 2019-05-03 | Treatment and prevention of metabolic diseases |
| GBGB1906597.8A GB201906597D0 (en) | 2019-05-03 | 2019-05-10 | Treatment and prevention of metabolic diseases |
| PH1/2021/552763A PH12021552763A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| BR112021021921A BR112021021921A2 (en) | 2019-05-03 | 2020-05-01 | Agent, use of an agent and method of treating or preventing a metabolic disease |
| CA3146344A CA3146344A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| JP2021564913A JP7595028B2 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| PCT/EP2020/062193 WO2020225147A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| MX2021013356A MX2021013356A (en) | 2019-05-03 | 2020-05-01 | TREATMENT AND PREVENTION OF METABOLIC DISEASES. |
| TW109114711A TW202108606A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| EP20721644.1A EP3962936A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| CN202080049108.3A CN114364693A (en) | 2019-05-03 | 2020-05-01 | Treatment and Prevention of Metabolic Diseases |
| KR1020217039250A KR20220050087A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| US16/865,259 US11813311B2 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| AU2020268619A AU2020268619A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
| CL2021002878A CL2021002878A1 (en) | 2019-05-03 | 2021-11-02 | Treatment and prevention of metabolic diseases |
| US18/482,399 US20240156913A1 (en) | 2019-05-03 | 2023-10-06 | Treatment and prevention of metabolic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1906291.8A GB201906291D0 (en) | 2019-05-03 | 2019-05-03 | Treatment and prevention of metabolic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201906291D0 true GB201906291D0 (en) | 2019-06-19 |
Family
ID=66641155
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1906291.8A Ceased GB201906291D0 (en) | 2019-05-03 | 2019-05-03 | Treatment and prevention of metabolic diseases |
| GBGB1906597.8A Ceased GB201906597D0 (en) | 2019-05-03 | 2019-05-10 | Treatment and prevention of metabolic diseases |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1906597.8A Ceased GB201906597D0 (en) | 2019-05-03 | 2019-05-10 | Treatment and prevention of metabolic diseases |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB201906291D0 (en) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2198931C2 (en) | 1990-06-11 | 2003-02-20 | Нексстар Фармасьютикалс Инк. | Method of identification of ligands, method of antibody preparing, method of selection of nucleic acid, method of nucleic acids mixture preparing, mixture of nucleic acids, nucleic acid ligand no occurring in nature |
| ES2093562B1 (en) | 1995-05-26 | 1997-07-01 | Univ Santiago Compostela | STABILIZATION OF COLLOID SYSTEMS THROUGH FORMATION OF LIPIDO-POLISACARIDO IONIC COMPLEXES. |
| US6649192B2 (en) | 1996-07-29 | 2003-11-18 | Universidade De Santiago De Compostela | Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| CA2237915A1 (en) | 1998-05-19 | 1999-11-19 | Stephen Shaughnessy | Osteoporosis treatment |
| WO2001029058A1 (en) | 1999-10-15 | 2001-04-26 | University Of Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| US8182814B2 (en) | 2007-10-26 | 2012-05-22 | Csl Limited | Methods of treating inflammatory airway conditions by inhibition of IL-11 activity |
| CA2703544C (en) | 2007-10-26 | 2016-01-05 | Manuel Baca | Cytokine muteins |
| US8518888B2 (en) | 2008-10-14 | 2013-08-27 | Csl Limited | Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R |
| PT2953971T (en) | 2013-02-07 | 2023-05-02 | Csl Ltd | Il-11r binding proteins and uses thereof |
| GB201522186D0 (en) | 2015-12-16 | 2016-01-27 | Singapore Health Services Pte Ltd And Nat University Of Singapore The | Treatment of fibrosis |
| MX2019007020A (en) | 2016-12-16 | 2019-10-21 | Singapore Health Serv Pte Ltd | Il-11 antibodies. |
| GB201621439D0 (en) | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore | IL-11Ra Antibodies |
| GB201621431D0 (en) | 2016-12-16 | 2017-02-01 | Singapore Health Services Pte Ltd And Nat Univ Of Singapore The | Decoy cytokine receptor |
-
2019
- 2019-05-03 GB GBGB1906291.8A patent/GB201906291D0/en not_active Ceased
- 2019-05-10 GB GBGB1906597.8A patent/GB201906597D0/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB201906597D0 (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3749264C0 (en) | Laser therapy for treatment and prevention of eye diseases | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| IL292810A (en) | Therapeutic compounds and methods of use | |
| IL276383A (en) | Treatment of ophthalmologic diseases | |
| IL287796A (en) | Compositions and methods for the treatment of atpase-mediated diseases | |
| EP3639833A4 (en) | Agent for the prevention or treatment of fat-related diseases and/or inflammation | |
| IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
| EP4054713A4 (en) | Compositions and methods for treatment or prevention of skin diseases and disorders with lekti | |
| IL287802A (en) | Compositions and methods for treatment of ocular diseases | |
| EP4058037A4 (en) | Fibroblast-based therapy for treatment and prevention of stroke | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases | |
| IL290891A (en) | Compositions and methods of treating vascular diseases | |
| IL287748A (en) | Treatment and detection of inherited neuropathies and associated disorders | |
| IL275925A (en) | Prevention and treatment of organ fibrosis | |
| EP3863621A4 (en) | Combination therapy for treatment and prevention of autoimmune and inflammatory diseases | |
| GB202015959D0 (en) | Treatment of diseases involving NAD | |
| IL276905A (en) | Treatment and prevention of pre-eclampsia | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| GB201906597D0 (en) | Treatment and prevention of metabolic diseases | |
| IL276121A (en) | Treatment and prevention of seed allergies | |
| IL270306A (en) | Prevention and treatment of pre-myeloid and myeloid malignancies | |
| GB201908544D0 (en) | Treatment and prevention of disease mediated by wwp2 | |
| GB202002030D0 (en) | Treatment and prevention of metabolic diseases | |
| GB202001896D0 (en) | Treatment and prevention of metabolic diseases | |
| GB202001013D0 (en) | Treatment and prevention of metabolic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |